INTERNATIONAL PATENT: IDORSIA PHARMACEUTICALS LTD FILES APPLICATION FOR "ARYL SULFONE AND SULFANONE DERIVATIVES AS OREXIN RECEPTOR MODULATORS"

GENEVA, Nov. 3 -- IDORSIA PHARMACEUTICALS LTD (Hegenheimermattweg 914123 Allschwil) filed a patent application (PCT/EP2025/061059) for "ARYL SULFONE AND SULFANONE DERIVATIVES AS OREXIN RECEPTOR MODULATORS" on Apr 23, 2025. With publication no. WO/2025/224168, the details related to the patent application was published on Oct 30, 2025.

Notably, the patent application was submitted under the International Patent Classification (IPC) system, which is managed by the World Intellectual Property Organization (WIPO).

Inventor(s): BEZENCON, Olivier (c/o Idorsia Pharmaceuticals LtdHegenheimermattweg 914123 Allschwil), HEIDMANN, Bibia (c/o Idorsia Pharmaceuticals LtdHegenheimermattweg 914123 Allschwil), MUEHLEMANN, Andreas (c/o Idorsia Pharmaceutic...